Program
tebipenem
Also written as “TBPM-PI-HBr”, “TBP-PI-HBr” and “Tebipenem pivoxil hydrobromide (TBPM-PI-HBr)”.
Its studies are mostly in Urinary Tract Infections · Pyelonephritis · Renal Insufficiency, led by Spero Therapeutics.
Drug pageTebipenem: every studyAll 13 studies of it, academic ones too, with its approvals, label and forms.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Spero Therapeutics | 120 open or running | phase 3since Dec 22, 2018 | Oct 19, 2017 | none ahead |
Also a collaborator on its studies: GlaxoSmithKline, Iqvia Pty, Clinartis, Covance, Celerion and CPR Pharma Services Pty Ltd, Australia.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Oct 19, 2017First study: phase 1 study in Healthy VolunteersFirst studyNCT03395249 · 124 enrolled · Australia
- Dec 22, 2018Phase 3 study in Complicated Urinary Tract InfectionNCT03788967 · 1,372 enrolled · United States, Bulgaria, Czechia and more
- Nov 14, 2019Phase 1 study in Renal InsufficiencyNCT04178577 · 39 enrolled · United States
- Jan 16, 2020Phase 1 study in TQT StudyNCT04238195 · 24 enrolled · United States
- Mar 16, 2020Phase 1 study in Healthy VolunteersNCT04376554 · 30 enrolled · Sweden
- Apr 9, 2020Phase 1 study in Healthy VolunteersNCT04368585 · 20 enrolled · United States
- Jun 4, 2020Phase 1 study in Healthy VolunteersNCT04421885 · 36 enrolled · United States
- Sep 17, 2020Phase 1 study in Healthy VolunteersNCT04625855 · 8 enrolled · United States
- Jan 4, 2021Phase 1 study in Healthy VolunteersNCT04710407 · 30 enrolled · United States
- May 3, 2023Phase 1 study in Healthy VolunteersNCT05856747 · 20 enrolled · United States
- Sep 22, 2023Phase 3 study in Urinary Tract InfectionsNCT06059846 · 1,690 enrolled · United States, Argentina, Bosnia and Herzegovina and more
- Dec 6, 2024Phase 1 study in Healthy ParticipantsNCT06727136 · 39 enrolled · United States
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 12 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT06727136Healthy Participants · United States | 1 | Completed | Apr 22, 2025 | 39 |
| NCT06059846Urinary Tract Infections · United States, Argentina, Bosnia and Herzegovina and more | 3 | Completed | Jan 27, 2025 | 1,690 |
| NCT05856747Healthy Volunteers · United States | 1 | Completed | Jun 1, 2023 | 20 |
| NCT04710407Healthy Volunteers · United States | 1 | Completed | Mar 10, 2021 | 30 |
| NCT04625855Healthy Volunteers · United States | 1 | Completed | Oct 16, 2020 | 8 |
| NCT04421885Healthy Volunteers · United States | 1 | Completed | Jul 11, 2020 | 36 |
| NCT04368585Healthy Volunteers · United States | 1 | Completed | Aug 8, 2020 | 20 |
| NCT04376554Healthy Volunteers · Sweden | 1 | Completed | Apr 6, 2021 | 30 |
| NCT04238195TQT Study · United States | 1 | Completed | Feb 26, 2020 | 24 |
| NCT04178577Renal Insufficiency · United States | 1 | Completed | Sep 6, 2020 | 39 |
| NCT03788967Complicated Urinary Tract Infection · United States, Bulgaria, Czechia and more | 3 | Completed | May 20, 2020 | 1,372 |
| NCT03395249Healthy Volunteers · Australia | 1 | Completed | Aug 2, 2018 | 124 |
How it is read
Names in the registry
- “TBPM-PI-HBr”, 4 entries
- “TBP-PI-HBr”, 3 entries
- “Tebipenem pivoxil hydrobromide (TBPM-PI-HBr)”, 2 entries
- “Tebipenem pivoxil hydrobromide (TBPM-PI-HBr) - Reference”, 1 entry
- “Tebipenem pivoxil hydrobromide (TBPM-PI-HBr) - Test”, 1 entry
Conditions, from the studies’ own filings
- Urinary Tract Infections, 1 study
- Pyelonephritis, 1 study
- Renal Insufficiency, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.